ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Eikon Therapeutics
The Director, High-Throughput Biology (HTB) at Eikon Therapeutics leads the strategy and evolution of the company’s high-throughput screening platforms, spanning automated and imaging-based technologies. Operating at the intersection of biology, automation engineering, and computational science, the role focuses on delivering scalable, robust data to support discovery programs. It emphasizes building a high-performing, cross-disciplinary team and establishing standards for assay robustness and data quality to enable efficient, portfolio-driven decision making.
Headquarters
Millbrae, California, United States
Company Size
201-500 employees
Founded
2019
Eikon Therapeutics is a biotechnology company that advances breakthrough therapeutics through the purposeful integration of science and engineering. The company has built a proprietary discovery platform that combines high‑resolution structural and single‑particle imaging (including cryo‑EM), automated experimental engineering, and computational/AI methods to map protein conformational landscapes and identify novel small‑molecule modulators. That platform is used to accelerate target identification, structure‑enabled design, and lead optimization across multiple therapeutic areas through internal programs and external partnerships. Headquartered in Cambridge, MA, Eikon emphasizes an engineering‑first approach to tackle challenging protein targets and shorten drug discovery timelines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eikon Therapeutics.
9% above the average for this role
IPO Tracker 2026: Generate Clocks Largest IPO Since 2024 With $400M Raise
2 weeks ago
Senior Scientist, Biology
Deep Apple Therapeutics
Lead Target Biology
Revolution Medicines
Associate Director | High-Throughput Biology
Digital Biology
Scientific Director, Lead Generation Biology
lifelancer
Scientist Manager, Cell & Systems Biology, CF-R&D
P&G
Research Associate/Senior Research Associate
Superluminal Medicines, Inc.
